Global Bioinformatics Market Size, Share, and COVID-19 Impact Analysis, By Product (Bioinformatics Platforms and Bioinformatics Services), By Application (Genomics, Cheminformatics, Metabolomics, and Proteomics), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Bioinformatics Market Insights Forecasts to 2035

• The Global Bioinformatics Market Size Was Estimated at USD 13.4 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 15.24% from 2025 to 2035
• The Worldwide Bioinformatics Market Size is Expected to Reach USD 63.8 Billion by 2035
• Asia Pacific is Expected to Grow the Fastest during the forecast period.

The Global Bioinformatics Market Size was worth around USD 13.4 Billion in 2024 and is predicted to grow to around USD 63.8 Billion by 2035 with a compound annual growth rate (CAGR) of 15.24% from 2025 and 2035. The bioinformatics market offers future opportunities in precision medicine, drug discovery, genomics, AI-driven data analysis, personalized healthcare solutions, biotechnology research, clinical diagnostics, big data integration, and growing demand for computational biology worldwide.

Global Bioinformatics Market Forecast and Revenue Outlook

• 2024 Market Size: USD 13.4 Billion
• 2035 Projected Market Size: USD 63.8 Billion
• CAGR (2025-2035): 15.24%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

The bioinformatics market refers to the integration of biology, computer science, and information technology to analyze and interpret complex biological data, particularly in genomics, proteomics, and drug discovery. Growing demand for personalized medicine, rapid advancements in next-generation sequencing (NGS), and rising adoption of artificial intelligence (AI) for predictive analysis are major driving factors. Government initiatives such as funding for genome projects and digital healthcare transformation are boosting adoption globally. Recent developments include cloud-based bioinformatics platforms and AI-powered tools for faster drug discovery. Statistically, over 60% of pharmaceutical and biotechnology companies are increasingly investing in bioinformatics solutions, while more than 70% of genomic research projects worldwide currently rely on advanced computational tools, highlighting its expanding role in modern life sciences and healthcare.

Key Market Insights

• North America is expected to account for the largest share in the Bioinformatics Market during the forecast period.
• In terms of Product, the Bioinformatics Services segment is projected to lead the Bioinformatics Market throughout the forecast period
• In terms of application, the Genomics segment captured the largest portion of the market

Bioinformatics Market Trends

• Increasing adoption of AI, machine learning, and cloud computing in data analysis.
• Expansion in drug discovery, biomarker identification, and clinical diagnostics.
• Growth of next-generation sequencing (NGS) and multi-omics technologies.
• Rising collaborations between pharma, biotech, and academic institutions.
• Increasing government and private funding for bioinformatics research.
• Shift toward cloud-based bioinformatics platforms for scalability and cost reduction.
• Focus on precision medicine and patient-specific therapeutic solutions.

Report Coverage

This research report categorizes the bioinformatics market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the bioinformatics market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the bioinformatics market.

Driving factors

The bioinformatics market is expanding rapidly due to the surge in genomics research, personalized medicine, and drug discovery initiatives. Increasing use of next-generation sequencing (NGS) has generated massive biological data, with over 2.5 million human genomes sequenced by 2024, fueling demand for advanced bioinformatics tools. Integration of AI and machine learning enhances predictive analytics in drug development and biomarker discovery. Government and private funding continues to rise, with the U.S. National Institutes of Health allocating over USD 600 million annually to bioinformatics programs. Growing collaborations between pharmaceutical, biotech, and academic institutions further accelerate market adoption globally.

Restraining Factor

The bioinformatics market faces restraints from high costs of advanced software and hardware, shortage of skilled professionals, data privacy concerns, and integration challenges with legacy systems. Additionally, the complexity of analyzing large multi-omics datasets limits broader adoption.

Market Segmentation 

The global bioinformatics market is divided into product and application.

Global Bioinformatics Market, By Product:

• The bioinformatics services segment dominated the market in 2024 and is projected to grow at approximately 14.47% CAGR during the forecast period.   

Based on product, the global bioinformatics market is segmented into, bioinformatics platforms and bioinformatics services. Among these, the bioinformatics Services segment dominated the market in 2024 and is projected to grow at approximately 14.47% CAGR during the forecast period. The bioinformatics services segment dominated in 2024 due to increased demand for skilled bioinformatics expertise, with over 70% of pharmaceutical companies outsourcing genomic data analysis. Growth is driven by complexity of multi-omics datasets, AI integration, and the need for customized analytical solutions.

The bioinformatics Platforms segment is expected to grow fastest due to rising adoption of cloud-based and AI-enabled platforms, with over 65% of life sciences organizations implementing advanced bioinformatics software. Platforms enable high-throughput data analysis, multi-omics integration, and scalable solutions for drug discovery. 

Global Bioinformatics Market, By Application:

• The genomics segment accounted for the largest share in 2024 and is anticipated to grow at a 16.1% CAGR during the forecast period.

Based on application, the global bioinformatics market is segmented into genomics, cheminformatics, metabolomics, and proteomics. Among these, the genomics segment accounted for the largest share in 2024 and is anticipated to grow at a 16.1% CAGR during the forecast period. This dominance is attributed to the increasing adoption of next-generation sequencing (NGS) technologies, which have become integral in various applications such as personalized medicine, drug discovery, and genetic disease research.

The proteomics segment in the bioinformatics market is expected to grow at the fastest CAGR over the forecast period. This growth is driven by the increasing demand for comprehensive protein analysis in drug discovery, disease biomarker identification, and personalized medicine. Proteomics applications are crucial for understanding complex biological systems and developing targeted therapies.

Regional Segment Analysis of the Global Bioinformatics Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America Bioinformatics Market Trends

North America is expected to hold the largest share of the global bioinformatics market over the forecast period.

North America is expected to hold the largest share of the global bioinformatics market over the forecast period. North America dominates the bioinformatics market due to strong R&D investments, advanced healthcare infrastructure, and presence of leading biotech and pharmaceutical companies. High adoption of personalized medicine, coupled with NIH and private funding programs, fosters innovation and drives regional market leadership.

U.S. Bioinformatics Market Trends

The U.S. bioinformatics market grows rapidly, driven by NIH initiatives like the All of Us Research Program, which aims to sequence over 1 million genomes. With chronic diseases affecting 6 in 10 Americans, demand for biomarker discovery and personalized medicine surges.

Canada Bioinformatics Market Trends

The Canada bioinformatics market is expanding due to CIHR-funded precision medicine programs and rising chronic disease prevalence, with nearly 44% of Canadians living with at least one chronic condition. Increasing use of genomics, proteomics, and NMR tools further accelerates adoption.

Asia Pacific is expected to grow at the fastest CAGR in the bioinformatics market during the forecast period.

Asia Pacific is expected to grow at the fastest CAGR in the bioinformatics market during the forecast period. Asia Pacific bioinformatics market is set for fastest growth due to rising healthcare investments, government genomics programs, and expanding biotech hubs in China, India, and Japan. With chronic diseases affecting over 250 million people regionally, demand for advanced diagnostics and personalized medicine surges.

India Bioinformatics Market Trends

The India bioinformatics market is accelerating with USD 500 million ICMR precision medicine funding, rising chronic disease burden affecting over 100 million diabetics, and expanding biotech R&D. Increased adoption of genomics, proteomics, and AI-driven bioinformatics tools is driving personalized healthcare solutions.

China Bioinformatics Market Trends

The China bioinformatics market is growing strongly, supported by government funding under initiatives like the Precision Medicine Project (USD 9 billion investment) and a chronic disease burden affecting over 350 million people. Expanding biotech R&D and genomics adoption fuel rapid market expansion.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global bioinformatics market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players in The Bioinformatics Market Include

• DNAnexus, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• IBM Corporation
• Labvantage - Biomax GmbH
• Genebio
• Compugen Ltd.
• Eurofins Scientific
• QIAGEN

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In February 2025, Bioinformatics analysis on skin cutaneous melanoma identifies five novel tumor antigens (P2RY6, PLA2G2D, RBM47, SEL1L3, SPIB) and two immune subtypes, enabling personalized mRNA vaccine strategies, especially for patients with “immune-cold” tumors showing low immune cell infiltration.

• In January 2025, Multi-omics and bioinformatics are transforming veterinary virology, revealing viral mutations like SARS-CoV-2 D614G and R203M/K, mapping host-pathogen gene networks, and enabling early detection of threats like LSDV. Proteomics further aids vaccine evaluation by identifying protein interactions critical for replication.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the bioinformatics market based on the following segments:

 Global Bioinformatics Market, By Product

• Bioinformatics Platforms
• Bioinformatics Services

Global Bioinformatics Market, By Application

• Genomics
• Cheminformatics
• Metabolomics
• Proteomics

Global Bioinformatics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa